Tuba Esfandyari
Papers
1
Total Citations
4
H-Index
1
About
Dr. Tuba Esfandyari is a leading gastroenterologist and researcher whose work focuses on gastroparesis, functional gastrointestinal disorders, and the therapeutic potential of ghrelin agonists. Her most cited study, a Phase 2 trial of TZP-102, demonstrated that this ghrelin agonist significantly alleviates key symptoms of gastroparesis—including nausea, early satiety, bloating, and abdominal pain—and that these improvements correlate strongly with patients’ overall rating of treatment effect. This research has been pivotal in advancing targeted therapies for a condition with limited treatment options, offering new hope for patients suffering from chronic gastric motility issues. With over 4 citations on this landmark paper, Dr. Esfandyari’s work continues to influence clinical approaches to managing gastroparesis. Her contributions underscore the importance of patient-reported outcomes in drug development and highlight her role in bridging translational research with real-world clinical care.
Research Focus
Key Achievements
Top Papers
- 1